Brief: Sensorion Receives FDA IND Approval For Arazasetron (Sens-401)

Sensorion SA

11/07/2019 09:27

July 11 (Reuters) - SENSORION SA  ALSEN.PA :
    * SENSORION RECEIVES FDA IND APPROVAL FOR ARAZASETRON (SENS-401)
    * INTERIM SAFETY RESULTS ARE EXPECTED AT END OF 2019 AND TOP LINE DATA WILL BE ANNOUNCED
MID- 2020
    * EUROPEAN MEDICINES AGENCY (EMA) HAS ACCEPTED ON 28TH OF JUNE 2019 PEDIATRIC INVESTIGATION
PLAN
(PIP) FOR BOTH DEVELOPMENTS IN TREATMENT OF SEVERE SUDDEN SENSORINEURAL HEARING LOSS (SSNHL) AND
FOR PREVENTION OF OTOTOXICITY CAUSED BY CISPLATIN (CIO) IN PEDIATRIC POPULATIONS

Source text for Eikon:  ID:nNDL6dl4PL 
Further company coverage:  ALSEN.PA 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))